Compare SBCF & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SBCF | CLDX |
|---|---|---|
| Founded | 1926 | N/A |
| Country | United States | United States |
| Employees | N/A | 198 |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.0B |
| IPO Year | 2009 | 1995 |
| Metric | SBCF | CLDX |
|---|---|---|
| Price | $33.98 | $36.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $38.00 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 749.7K | 684.9K |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | ★ 10.56 | N/A |
| EPS | ★ 0.84 | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | $45.04 | $111.39 |
| Revenue Next Year | $6.30 | $235.85 |
| P/E Ratio | $40.31 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $28.58 | $22.10 |
| 52 Week High | $36.27 | $45.14 |
| Indicator | SBCF | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 45.14 | 42.99 |
| Support Level | $32.83 | $28.51 |
| Resistance Level | $34.50 | $40.30 |
| Average True Range (ATR) | 0.65 | 1.26 |
| MACD | -0.10 | -0.37 |
| Stochastic Oscillator | 43.13 | 18.54 |
Seacoast Banking Corp of Florida is a holding company. The company provides integrated financial services, including commercial and consumer banking, wealth management, and mortgage and insurance services, to customers across Florida through branch, mobile, and online banking solutions. It maintains day-to-day operations, particularly in the areas of operations, treasury management systems, information technology, and security. The company has one reportable segment that provides these integrated financial services, with segment revenues driven mainly by interest and fees on loans, interest on cash and cash equivalents, and investment securities, and fees on depository products and services.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.